What if I told you the pharma industry losing $250B in revenue wasn’t a crisis—but a success? The patent cliff is back in the headlines. I believe it’s being widely misunderstood—and that the real problem lies elsewhere.

Despite Europe’s reputation for scientific leadership, the truth is that patients across the continent are waiting longer, and often in...

Ireland's biopharma sector is a world-class success story, but what worked in the past will not lead to future success. We've spent...